First clinical case of a locally acquired carbapenem-resistant VIM-1 metallo-beta-lactamase in Pseudomonas aeruginosa in Australia.

Subjects

Subjects :

Aged, 80 and over
Australia
Humans
Male
Pseudomonas Infections microbiology
Pseudomonas aeruginosa drug effects
beta-Lactamases therapeutic use
Carbapenems therapeutic use
Pseudomonas Infections drug therapy
Pseudomonas aeruginosa isolation & purification
beta-Lactam Resistance

Details

Language :

English

ISSN :

0025-729X

Volume :

191

Issue :

5

Database :

MEDLINE

Journal :

The Medical journal of Australia

Publication Type :

Report

Accession number :

19740057

Full Text :

https://doi.org/10.5694/j.1326-5377.2009.tb02791.x